Skip to content

PHARM-AD: what changed

BE 0819.236.165NACE 82.990, Other business support servicesOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€150,580
2024 · €179,337-€28,757
Equity
€476,654
2024 · €473,184+€3,470
Cash
€344,323
2024 · €406,112-€61,789
Balance sheet total
€659,306
2024 · €732,939-€73,633

Largest movements

2024 to 2025
Assets
  • Cash -€61,789

    down €61,789 (-15.2%), from €406,112 to €344,323

    mainly Contributions, distributions and other (-€147,110) and Trade debts (-€33,569)

  • Receivables within one year -€33,302

    down €33,302 (-25.1%), from €132,503 to €99,201

    of which Trade receivables: -€33,776

  • Current investments +€11,891

    up €11,891 (+6.2%), from €190,373 to €202,264

  • Tangible fixed assets +€8,279

    up €8,279 (+210%), from €3,951 to €12,229

    of which Assets under construction and advance payments: +€8,677

Equity and liabilities
  • Trade debts -€33,569

    down €33,569 (-100%), from €33,569 to €0

  • Tax, wage and social debts -€32,588

    down €32,588 (-44.7%), from €72,827 to €40,240

Income statement
  • Gross operating margin -€40,285

    down €40,285 (-15.3%), from €262,607 to €222,322

  • Taxes -€13,864

    down €13,864 (-17.0%), from €81,411 to €67,547

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €179,337
Gross operating margin -€40,285
Depreciation -€25
Other operating charges -€988
Financial income +€312
Financial charges -€1,635
Taxes +€13,864
Result 2025 €150,580
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€105,778
Investment -€20,458
Financing -€147,110
Cash 2024 €406,112
Net result for the year +€150,580
Depreciation +€288
Receivables within one year +€33,302
Deferred charges and accrued income -€1,289
Trade debts -€33,569
Tax, wage and social debts -€32,588
Other debts -€5,076
Accrued charges and deferred income -€5,870
Investment in fixed assets (net) -€8,567
Current investments -€11,891
Contributions, distributions and other -€147,110
Cash 2025 €344,323
brings cash intakes cash out
Every line side by side 38 lines
Line Code 2024 2025 Change %
Total assets 20/58 €732,939 €659,306 -€73,633 -10.0%
Fixed assets 21/28 €3,951 €12,229 +€8,279 +210%
Tangible fixed assets 22/27 €3,951 €12,229 +€8,279 +210%
Land and buildings 22 €3,951 €3,552 -€399 -10.1%
Assets under construction and advance payments 27 - €8,677 +€8,677
Current assets 29/58 €728,988 €647,077 -€81,911 -11.2%
Amounts receivable within one year 40/41 €132,503 €99,201 -€33,302 -25.1%
Trade receivables 40 €132,372 €98,596 -€33,776 -25.5%
Other amounts receivable 41 €131 €605 +€475 +363%
Current investments 50/53 €190,373 €202,264 +€11,891 +6.2%
Cash at bank and in hand 54/58 €406,112 €344,323 -€61,789 -15.2%
Deferred charges and accrued income 490/1 - €1,289 +€1,289
Total equity and liabilities 10/49 €732,939 €659,306 -€73,633 -10.0%
Equity 10/15 €473,184 €476,654 +€3,470 +0.7%
Contributions 10/11 €6,200 €6,200 = 0.0%
Reserves 13 €465,787 €469,257 +€3,470 +0.7%
Distributable reserves 133 €465,787 €469,257 +€3,470 +0.7%
Profit (loss) carried forward 14 €1,197 €1,197 = 0.0%
Amounts payable 17/49 €259,755 €182,653 -€77,102 -29.7%
Amounts payable within one year 42/48 €253,885 €182,653 -€71,232 -28.1%
Trade debts 44 €33,569 €0 -€33,569 -100%
Suppliers 440/4 €33,569 €0 -€33,569 -100%
Taxes, remuneration and social security 45 €72,827 €40,240 -€32,588 -44.7%
Taxes 450/3 €72,827 €40,240 -€32,588 -44.7%
Other amounts payable 47/48 €147,489 €142,413 -€5,076 -3.4%
Accrued charges and deferred income 492/3 €5,870 €0 -€5,870 -100%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €263 €288 +€25 +9.5%
Other operating charges 640/8 €740 €1,728 +€988 +134%
Gross operating margin 9900 €262,607 €222,322 -€40,285 -15.3%
Operating profit (loss) 9901 €261,604 €220,306 -€41,298 -15.8%
Financial income 75/76B €1,628 €1,939 +€312 +19.2%
Recurring financial income 75 €1,628 €1,939 +€312 +19.2%
Financial charges 65/66B €2,484 €4,118 +€1,635 +65.8%
Recurring financial charges 65 €2,484 €4,118 +€1,635 +65.8%
Profit (loss) for the period before taxes 9903 €260,747 €218,127 -€42,620 -16.3%
Income taxes 67/77 €81,411 €67,547 -€13,864 -17.0%
Profit (loss) for the period 9904 €179,337 €150,580 -€28,757 -16.0%
Profit (loss) for the period to be appropriated 9905 €179,337 €150,580 -€28,757 -16.0%

Value

latest balance sheet 30-06-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€725,309 to €920,102

Midpoint €806,473 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €476,654
Capitalised earnings €973,964 to €1.4m
Indication €725,309 to €920,102

Adjusted equity

balance sheet 30-06-2025
Equity (10/15)
€476,654
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€476,654

Capitalised earnings

net result for the year (9904)
2025
€150,580
2024
€179,337
2023
€80,487
excluding non-recurring income and charges
€79,147
2022
€57,286
2021
€51,417
Average result, excluding non-recurring income and charges
€136,355
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€973,964 / €1.1m / €1.4m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 30 June 2024 and 30 June 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 19 November 2026 via checked.be.